Pan, Hanbo
Tian, Yu
Pei, Siyu
Yang, Wanlin
Zhang, Yanyang
Gu, Zenan
Zhu, Hongda
Zou, Ningyuan
Zhang, Jiaqi
Jiang, Long
Hu, Yingjie
Shen, Shengping
Wang, Kai
Jin, Haizhen
Li, Ziming
Zhang, Yanyun
Xiao, Yichuan
Luo, Qingquan
Wang, Hui
Huang, Jia
Funding for this research was provided by:
China Postdoctoral Science Foundation (2021M693272, 2021M700160)
CAS Project for Young Scientist in Basic Research (YSBR-076)
National Natural Science Foundation of China (82201924, 82001657, 81972176, 82030041)
National Key R&D Program of China (2018YFA0107201, 2018YFA0902703)
Strategic Priority Research Program of the Chinese Academy of Sciences (XDB39030300)
Shanghai Municipal Science and Technology (20XD1424600, 21140905000)
Article History
Received: 29 October 2023
Accepted: 7 May 2024
First Online: 17 May 2024
Declarations
:
: This study was approved by the Institutional Review Board of Shanghai Lung Tumor Clinical Medical Center, Shanghai Chest Hospital [approval number: KS(Y)23072]. All animal experiments were carried out following the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the institutional biomedical research ethics committee of Shanghai Jiao Tong University. Additionally, all procedures involving human participants followed the Declaration of Helsinki (revised in 2013). Informed consent was collected from each involved case before their enrollment in the study.
: Not applicable.
: The authors declare no competing interests.